(Q67859202)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1791308%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Estrogen, progesterone receptors and proliferating activity evaluated by immunocytochemistry in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1791308%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Estrogen, Progesterone Receptors and Proliferating Activity Evaluated by Immunocytochemistry in Breast Cancer (English)

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

27 November 2022

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

27 November 2022

1

D. Campani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791308

27 November 2022

author name string

F. De Negri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791308

27 November 2022

R. Fabbri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791308

27 November 2022

L. Martini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791308

27 November 2022

C. Giani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791308

27 November 2022

F. Squartini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791308

27 November 2022

R. Sarnelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791308

27 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1791308

27 November 2022

publication date

1 July 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1791308%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

http://journals.sagepub.com/doi/pdf/10.1177/172460089100600302

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

The International Journal of Biological Markers

27 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1791308%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1791308%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

144-150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1791308%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1791308%20AND%20SRC:MED&resulttype=core&format=json

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables

27 November 2022

2

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Kinetic parameters and the course of the disease in breast cancer

27 November 2022

5

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Relationship between proliferative activity and estrogen receptors in breast cancer

27 November 2022

6

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Cell proliferation and its relationship to clinical features and relapse in breast cancers

27 November 2022

8

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

27 November 2022

11

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response

27 November 2022

12

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease-free survival, and clinical endocrine response

27 November 2022

13

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization

27 November 2022

14

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

The pathology of invasive breast cancerA Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4)

27 November 2022

15

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Steroid receptors in breast cancer: historical perspective

27 November 2022

17

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

The value of estrogen and progesterone receptors in the treatment of breast cancer

27 November 2022

18

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Steroid-hormone receptors in breast cancer

27 November 2022

19

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients

27 November 2022

20

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors

27 November 2022

21

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer

27 November 2022

22

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Improved sensitivity in the measurement of estrogen receptor in human breast cancer.

27 November 2022

23

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells

27 November 2022

24

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols

27 November 2022

28

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer

27 November 2022

31

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Comparative evaluation of ER-ICA and enzyme immunoassay for the quantitation of estrogen receptors in breast cancer

27 November 2022

33

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Estrogen receptor analyses in breast cancer: comparison of monoclonal immunohistochemical and biochemical methods

27 November 2022

34

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Cell kinetics as a prognostic marker in node-negative breast cancer.

27 November 2022

35

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

27 November 2022

38

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables

27 November 2022

39

1 reference

https://api.crossref.org/works/10.1177/172460089100600302

27 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1791308%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference